This is a standard procedural filing. Traders should note that no new information was disclosed, and the vote on executive compensation is non-binding. Monitor for any activist shareholder activity or unexpected director nominations in future filings.
LH drugs
LH drug pipeline →How the stock moved after the report
NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · Apr 10 $260.93entry
- T+1 · 7mo ago +1.25%α +0.27% · $264.18
- T+5 · 7mo ago +3.74%α −0.77% · $270.68
- T+20 · 6mo ago −1.10%α −9.63% · $258.05
- T+60 · 4mo ago +8.79%α −1.54% · $283.86
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Labcorp Holdings Inc. has filed a definitive proxy statement for its 2026 Annual Meeting, where shareholders will vote on the election of directors, approval of executive compensation, and ratification of the independent auditor. This is a routine annual filing with no new material events announced.
Key Financial Metrics
Key Facts
- The filing is a definitive proxy statement (DEFA14A) for the 2026 Annual Meeting.
- Shareholders will vote on three proposals: election of 11 directors, approval of executive compensation, and ratification of the independent auditor.
- The meeting will be held virtually on May 21, 2026.
- No new financial results, strategic changes, or material events are disclosed in this filing.
Financial Impact
Routine annual filing with no immediate financial impact.
Risk Factors
- None identified from this filing.
- The filing itself carries no financial risk.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| DEFA14A Filing (Primary) | 0001193125-26-150762 |
| Document: 0001193125-26-150762-index-headers.html | 0001193125-26-150762 |
| Document: 0001193125-26-150762-index.html | 0001193125-26-150762 |
| Document: 0001193125-26-150762.txt | 0001193125-26-150762 |
Track record
29 reports on LH
5 of 5 bullish or bearish reports moved the stock their way by T+5. Best: +17.60% at T+60 after the Apr 30, 2026 report. 5 of 5 went positive at some point.
Filters
- Nov 12, 20264d ago Insider Cluster Neutral 2/10 Entry $372.32 Now $372.46 +0.04% settles Nov 19
- Nov 10, 20266d ago 144 Neutral 2/10 Entry $372.23 Now $372.46 +0.06% settles Nov 18
- Nov 5, 202611d ago Insider Cluster Neutral 2/10 Entry $363.30 to $372.32 Now $372.46 +2.52% ▲ +2.48% −0.81% vs SPY
- Nov 4, 202612d ago 144 Neutral 2/10 Entry $367.79 to $372.23 Now $372.46 +1.27% ▲ +1.21% +2.12% vs SPY
- Nov 4, 202612d ago 8-K Neutral 2/10 Entry $367.79 to $372.23 Now $372.46 +1.27% ▲ +1.21% +2.12% vs SPY
- Nov 3, 202613d ago 144 Neutral 2/10 Entry $353.92 to $370.88 Now $372.46 +5.24% ▲ +4.79% +5.38% vs SPY
- Oct 30, 202617d ago 144 Neutral 2/10 Entry $361.39 to $366.57 Now $372.46 +3.06% ▲ +1.43% +4.14% vs SPY
- Oct 28, 202619d ago 8-K Bullish 6/10 Entry $360.25 to $367.79 Now $372.46 +3.39% ▲ +2.09% +2.81% vs SPY
- Oct 26, 202621d ago Institutional Cluster Neutral 3/10 Entry $329.90 to $361.39 Now $372.46 +12.90% ▲ +9.55% +10.81% vs SPY
- Oct 21, 202626d ago 8-K Neutral 2/10 Entry $323.75 to $331.17 Now $372.46 +15.05% ▲ +2.29% +2.74% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers